Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1270888

registered interest
date	14/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of access to covid-19 vaccines for (a) people with learning disabilities and (b) autistic people, with particular reference to people living in in-patient settings.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	129068
answer	answer is ministerial correction date of answer 22/12/2020 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI), the independent body of clinical experts, advise the Government on which vaccine/s the United Kingdom should use and provide advice on prioritisation including for the COVID-19 vaccine.</p><p>The vaccine is initially being rolled out to priority groups considered to be the most at risk and frontline health and social care workers, then to the rest of the population in order of age and risk, including those who are clinically extremely vulnerable and all individuals aged 16-64 years old with underlying health conditions. The JCVI’s advice is published at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/940396/Priority_groups_for_coronavirus__COVID-19__vaccination_-_advice_from_the_JCVI__2_December_2020.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/940396/Priority_groups_for_coronavirus__COVID-19__vaccination_-_advice_from_the_JCVI__2_December_2020.pdf</a></p><p>People with a learning disability who are clinically extremely vulnerable, including adults with Down's syndrome, and people with a severe and profound learning disability are prioritised to receive the vaccine; and are within fourth and sixth vaccine prioritisation groups respectively. This applies to all care settings, and many younger adults in residential care settings will be eligible for a prioritised vaccine because they fall into one of the clinical risk groups, for example learning disabilities. Given the high risk of exposure in these settings, where a high proportion of the population would be considered eligible, prioritised vaccination of the whole resident population is recommended.</p><p>Throughout the pandemic officials from the Department have joined regular fortnightly meetings with learning disability and autism stakeholders to discuss the response to the pandemic and its impacts on people with a learning disability and autism.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 129069 question first answered 22/12/2020 11:57:47 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 70173 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1270889

registered interest
date	14/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions his Department is having with officials and campaign groups on the prioritisation of people with learning disabilities and autistic people, including those living in in-patient settings, for covid-19 vaccines.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	129069
answer	answer is ministerial correction date of answer 22/12/2020 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI), the independent body of clinical experts, advise the Government on which vaccine/s the United Kingdom should use and provide advice on prioritisation including for the COVID-19 vaccine.</p><p>The vaccine is initially being rolled out to priority groups considered to be the most at risk and frontline health and social care workers, then to the rest of the population in order of age and risk, including those who are clinically extremely vulnerable and all individuals aged 16-64 years old with underlying health conditions. The JCVI’s advice is published at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/940396/Priority_groups_for_coronavirus__COVID-19__vaccination_-_advice_from_the_JCVI__2_December_2020.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/940396/Priority_groups_for_coronavirus__COVID-19__vaccination_-_advice_from_the_JCVI__2_December_2020.pdf</a></p><p>People with a learning disability who are clinically extremely vulnerable, including adults with Down's syndrome, and people with a severe and profound learning disability are prioritised to receive the vaccine; and are within fourth and sixth vaccine prioritisation groups respectively. This applies to all care settings, and many younger adults in residential care settings will be eligible for a prioritised vaccine because they fall into one of the clinical risk groups, for example learning disabilities. Given the high risk of exposure in these settings, where a high proportion of the population would be considered eligible, prioritised vaccination of the whole resident population is recommended.</p><p>Throughout the pandemic officials from the Department have joined regular fortnightly meetings with learning disability and autism stakeholders to discuss the response to the pandemic and its impacts on people with a learning disability and autism.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 129068 question first answered 22/12/2020 11:57:47 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 70174 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4510 label Biography information for Helen Hayes

1260538

registered interest
date	11/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Life Sciences: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to promote the UK as a destination for life sciences innovation, in the context of the Medicines and Healthcare products Regulatory Agency (MHRA) becoming the first regulator to approve the mRNA vaccine for covid-19 on 2 December 2020.
tabling member constituency	Ashfield
tabling member printed	Lee Anderson
uin	128730
answer	answer is ministerial correction date of answer 21/12/2020 answer text <p>The flexibility and pragmatism of the MHRA has been instrumental to our COVID response, including enabling us to approve the COVID-19 vaccine before any other country. The MHRA will continue to pioneer innovative regulatory approaches to the most ground-breaking treatments, from the latest AI-enabled technologies to the best new precision therapies, benefiting both patients and the sector.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 21/12/2020 12:03:33 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4743 label Biography information for Lee Anderson

1260612

registered interest
date	11/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Britishvolt: Blyth
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department plans to provide financial support to the planned new Britishvolt factory in Blyth.
tabling member constituency	Dwyfor Meirionnydd
tabling member printed	Liz Saville Roberts
uin	128707
answer	answer is ministerial correction date of answer 21/12/2020 answer text <p>I welcome Britishvolt’s announcement. As my Rt hon Friend the Prime Minister set out recently in his 10 Point Plan, manufacturing electric vehicles and developing the required supply chain right here in the UK is a key part of building back better and greener. A Gigafactory will support industry, provide high quality jobs and help the automotive sector transform over the coming decade - as we make strides towards our world-beating net zero goals.</p><p> </p><p>The Government has announced nearly £500m of support through the Automotive Transformation Fund to drive the electrification of the UK automotive sector. This is part of the up to £1 billion that this government previously committed to these efforts. The application process is managed by the Advanced Propulsion Centre on behalf of BEIS and funding will be allocated on a competitive basis, dependent on a full assessment of the relative value for money of any request received.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 128708 question first answered 21/12/2020 14:09:42 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4521 label Biography information for Liz Saville Roberts

1260613

registered interest
date	11/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Britishvolt: Blyth
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether he has had discussions with representatives of Britishvolt on its planned factory in Blyth.
tabling member constituency	Dwyfor Meirionnydd
tabling member printed	Liz Saville Roberts
uin	128708
answer	answer is ministerial correction date of answer 21/12/2020 answer text <p>I welcome Britishvolt’s announcement. As my Rt hon Friend the Prime Minister set out recently in his 10 Point Plan, manufacturing electric vehicles and developing the required supply chain right here in the UK is a key part of building back better and greener. A Gigafactory will support industry, provide high quality jobs and help the automotive sector transform over the coming decade - as we make strides towards our world-beating net zero goals.</p><p> </p><p>The Government has announced nearly £500m of support through the Automotive Transformation Fund to drive the electrification of the UK automotive sector. This is part of the up to £1 billion that this government previously committed to these efforts. The application process is managed by the Advanced Propulsion Centre on behalf of BEIS and funding will be allocated on a competitive basis, dependent on a full assessment of the relative value for money of any request received.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 128707 question first answered 21/12/2020 14:09:42 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4521 label Biography information for Liz Saville Roberts

1259877

registered interest
date	09/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the £6 billion announced in the Spending Review 2020 for development and procurement of vaccines is inclusive of existing covid-19 vaccine procurement contracts.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	127551
answer	answer is ministerial correction date of answer 14/12/2020 answer text <p>Yes, the £6 billion announced in the Spending Review 2020 for development and procurement of vaccines is inclusive of existing covid-19 vaccine procurement contracts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/12/2020 17:02:39 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4124 label Biography information for Chi Onwurah

1258265

registered interest
date	03/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to introduce a form of proof for people who have received a covid-19 vaccine.
tabling member constituency	South Leicestershire
tabling member printed	Alberto Costa
uin	124776
answer	answer is ministerial correction date of answer 22/12/2020 answer text <p>The careful and accurate recording of vaccination status is incredibly important both in terms of ensuring priority cohorts are offered the two doses of a COVID-19 vaccination, and to ensure robust surveillance systems are in place to support patient safety.</p><p>The National Health Service’s National Immunisation Management System (NIMS) will be used as the national register of COVID-19 vaccinations. At the point that someone receives their COVID-19 vaccine, the vaccinating team will record it and this information will go onto the NIMS system and onto a patient’s general practice record.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/12/2020 12:02:33 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4439 label Biography information for Alberto Costa

1257567

registered interest
date	02/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether it is his policy that (a) the elderly and (b) pregnant women will receive the covid-19 vaccine first.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	124187
answer	answer is ministerial correction date of answer 22/12/2020 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) consists of independent experts who advise the Government on which vaccine the United Kingdom should use and provide advice on prioritisation at a population level. The JCVI has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of COVID-19 mortality and the protection of health and social care staff and systems.</p><p>Therefore, in line with the recommendations of the JCVI, the vaccine will be initially rolled out to these priority groups including care home residents and staff, people over 80 years old, and health and care workers. The vaccine will then be prioritised amongst the rest of the population in order of age and risk, including those who are clinically extremely vulnerable, and all individuals aged 16-64 years old with underlying health conditions.</p><p>The JCVI favours a precautionary approach and does not currently advise COVID-19 vaccination in pregnancy.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/12/2020 12:12:56 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1257586

registered interest
date	02/12/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, how many people with (a) cancer, (b) fibromyalgia, (c) multiple sclerosis and (d) other serious conditions each of the covid-19 vaccines have been tested on.
tabling member constituency	North West Durham
tabling member printed	Mr Richard Holden
uin	124337
answer	answer is ministerial correction date of answer 07/12/2020 answer text <p>Individuals with certain medical conditions are not specific trial groups, but safety data will be coming from all trials to set out how the COVID-19 vaccines work in different types of people. <br> <br> The NHS Covid-19 vaccine research registry, developed in partnership with NHS Digital, will help facilitate the rapid recruitment of large numbers of people into trials. The Government has been encouraging a diverse pool of people to volunteer to help researchers better understand the effectiveness of each vaccine candidate.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 07/12/2020 16:08:38 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4813 label Biography information for Mr Richard Holden

1257651

registered interest
date	02/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of the general population is required to take up a covid-19 vaccination to ensure the effectiveness of that vaccination programme.
tabling member constituency	Nottingham North
tabling member printed	Alex Norris
uin	124291
answer	answer is ministerial correction date of answer 22/12/2020 answer text <p>It has not yet been determined what proportion of the general population is required to take up a COVID-19 vaccination.</p><p> </p><p>The Joint Committee on Vaccination and Immunisation (JCVI) advised that the first priorities for any COVID-19 vaccination programme should be the prevention of COVID-19 mortality and the protection of health and social care staff and systems. The JCVI recently published advice to facilitate the development of policy on COVID-19 vaccination in the United Kingdom with the priority list for COVID-19 vaccination. It is estimated that taken together, these groups represent around 99% of preventable mortality from COVID-19.</p><p> </p><p>As the first phase of the programme is rolled out in the UK, additional data will become available on the safety and effectiveness of COVID-19 vaccines and whether they can prevent infection and onward transmission in the population.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/12/2020 11:54:27 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 67386 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4641 label Biography information for Alex Norris